| P50 | author | Asla Pitkänen | Q23039734 |
| | Andrew J Cole | Q57009170 |
| P2093 | author name string | Matthias J Koepp | |
| | Heidrun Potschka | |
| | Alon Friedman | |
| | Paolo Federico | |
| | Riikka Immonen | |
| | Stefanie Dedeurwaerdere | |
| | Erwin A van Vliet | |
| P2860 | cites work | Interictal arterial spin-labeling MRI perfusion in intractable epilepsy. | Q48487106 |
| | Who needs a Wada test? Present clinical indications for amobarbital procedures | Q48625738 |
| | Proton spectroscopic imaging at 4.1 tesla in patients with malformations of cortical development and epilepsy | Q48745564 |
| | Patterns of human local cerebral glucose metabolism during epileptic seizures | Q48891111 |
| | Layer specific tracing of corticocortical and thalamocortical connectivity in the rodent using manganese enhanced MRI. | Q48947963 |
| | Brain inflammation in a chronic epilepsy model: Evolving pattern of the translocator protein during epileptogenesis. | Q50707751 |
| | [11C]quinidine and [11C]laniquidar PET imaging in a chronic rodent epilepsy model: impact of epilepsy and drug-responsiveness. | Q50857954 |
| | P-glycoprotein expression and function in patients with temporal lobe epilepsy: a case-control study. | Q50891100 |
| | Diffusion tensor imaging of hippocampal network plasticity. | Q54406308 |
| | Recommendations for Neuroimaging of Patients with Epilepsy | Q58417209 |
| | In vivo PET imaging demonstrates diminished microglial activation after fingolimod treatment in an animal model of multiple sclerosis | Q86497271 |
| | Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies | Q24642726 |
| | Structure and function of the blood-brain barrier | Q29615699 |
| | Effects of benzodiazepines on triphasic waves: implications for nonconvulsive status epilepticus | Q30308178 |
| | Epilepsy biomarkers. | Q30411290 |
| | Characterization of atypical language activation patterns in focal epilepsy | Q30421480 |
| | EEG-fMRI: adding to standard evaluations of patients with nonlesional frontal lobe epilepsy. | Q30494799 |
| | MRI biomarkers for post-traumatic epileptogenesis | Q30541547 |
| | Preoperative language lateralization in temporal lobe epilepsy (TLE) predicts peri-ictal, pre- and post-operative language performance: An fMRI study. | Q30554282 |
| | Working memory network plasticity after anterior temporal lobe resection: a longitudinal functional magnetic resonance imaging study | Q30577006 |
| | Quantitative imaging assessment of blood-brain barrier permeability in humans. | Q30587216 |
| | Memory fMRI predicts verbal memory decline after anterior temporal lobe resection | Q30642873 |
| | Electroencephalography/functional magnetic resonance imaging responses help predict surgical outcome in focal epilepsy | Q30657453 |
| | Neuroimaging of drug resistance in epilepsy | Q30760490 |
| | Clinical proton MR spectroscopy in central nervous system disorders | Q30764446 |
| | Imaging brain inflammation in epilepsy | Q30848411 |
| | Blood-brain barrier imaging in human neuropathologies | Q30873200 |
| | Analyzing the blood-brain barrier: the benefits of medical imaging in research and clinical practice | Q30873284 |
| | Neuronuclear assessment of patients with epilepsy. | Q31157115 |
| | Blood-brain barrier dysfunction and epilepsy: pathophysiologic role and therapeutic approaches | Q33354141 |
| | Independent component analysis reveals dynamic ictal BOLD responses in EEG-fMRI data from focal epilepsy patients | Q33489243 |
| | Can structural or functional changes following traumatic brain injury in the rat predict epileptic outcome? | Q33655350 |
| | Imaging memory in temporal lobe epilepsy: predicting the effects of temporal lobe resection | Q33773486 |
| | P-glycoprotein function at the blood-brain barrier in humans can be quantified with the substrate radiotracer 11C-N-desmethyl-loperamide | Q33797745 |
| | A novel, noninvasive, predictive epilepsy biomarker with clinical potential | Q33801568 |
| | The neurochemical profile quantified by in vivo 1H NMR spectroscopy | Q34121273 |
| | Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971. | Q34408079 |
| | Blood-brain barrier breakdown following traumatic brain injury: a possible role in posttraumatic epilepsy. | Q34664968 |
| | Co-localization between the BOLD response and epileptiform discharges recorded by simultaneous intracranial EEG-fMRI at 3 T. | Q35221969 |
| | White matter abnormalities differentiate severe from benign temporal lobe epilepsy. | Q35670049 |
| | Distributions of Irritative Zones Are Related to Individual Alterations of Resting-State Networks in Focal Epilepsy | Q35727280 |
| | Increased permeability-glycoprotein inhibition at the human blood-brain barrier can be safely achieved by performing PET during peak plasma concentrations of tariquidar | Q35831488 |
| | Contribution of EEG/fMRI to the definition of the epileptic focus | Q35937963 |
| | Detection of calcifications in vivo and ex vivo after brain injury in rat using SWIFT. | Q36035497 |
| | Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography | Q36049576 |
| | Advances in PET imaging of P-glycoprotein function at the blood-brain barrier | Q36638627 |
| | Brain inflammation as a biomarker in epilepsy | Q36763895 |
| | Bringing memory fMRI to the clinic: comparison of seven memory fMRI protocols in temporal lobe epilepsy | Q36866305 |
| | Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery | Q37110603 |
| | (R)-[(11)C]verapamil is selectively transported by murine and human P-glycoprotein at the blood-brain barrier, and not by MRP1 and BCRP. | Q37177013 |
| | Disrupted segregation of working memory networks in temporal lobe epilepsy | Q37184573 |
| | Increased in vivo expression of an inflammatory marker in temporal lobe epilepsy. | Q37322082 |
| | 1H MRSI predicts surgical outcome in MRI-negative temporal lobe epilepsy | Q37348514 |
| | Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein | Q37584734 |
| | Past and present definitions of epileptogenesis and its biomarkers | Q37717423 |
| | The role of inflammation in epilepsy | Q37816957 |
| | Radioligands targeting P-glycoprotein and other drug efflux proteins at the blood-brain barrier. | Q38166961 |
| | Blood-brain barrier dysfunction, seizures and epilepsy | Q38274766 |
| | Language lateralization in temporal lobe epilepsy: a comparison between fMRI and the Wada Test | Q38404466 |
| | Clinical Applications of Simultaneous PET/MR Imaging Using (R)-[11C]-Verapamil with Cyclosporin A: Preliminary Results on a Surrogate Marker of Drug-Resistant Epilepsy. | Q38420352 |
| | Abnormalities of lexical and semantic processing in left temporal lobe epilepsy: an fMRI study | Q38484791 |
| | Metabolic Correlates of the Ictal-Interictal Continuum: FDG-PET During Continuous EEG. | Q38832437 |
| | (R)-[11C]PK11195 brain uptake as a biomarker of inflammation and antiepileptic drug resistance: evaluation in a rat epilepsy model. | Q39183565 |
| | Longitudinal assessment of blood-brain barrier leakage during epileptogenesis in rats. A quantitative MRI study | Q39298425 |
| | PET imaging of brain inflammation during early epileptogenesis in a rat model of temporal lobe epilepsy. | Q39523354 |
| | Transport of selected PET radiotracers by human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2): an in vitro screening. | Q39592140 |
| | Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats I: Magnetic resonance imaging | Q40183729 |
| | Blood-brain barrier leakage after status epilepticus in rapamycin-treated rats II: Potential mechanisms. | Q40183907 |
| | Elevated cerebral blood flow and vascular density in the amygdala after status epilepticus in rats. | Q42937516 |
| | Magnetic resonance imaging in the study of the lithium-pilocarpine model of temporal lobe epilepsy in adult rats | Q43959043 |
| | In vivo imaging of glia activation using 1H-magnetic resonance spectroscopy to detect putative biomarkers of tissue epileptogenicity. | Q44258943 |
| | Myoinositol abnormalities in temporal lobe epilepsy. | Q44468351 |
| | Creutzfeldt-Jakob disease and non-convulsive status epilepticus: a clinical and electroencephalographic follow-up study | Q44742971 |
| | Serial Quantitative TSPO-Targeted PET Reveals Peak Microglial Activation up to 2 Weeks After an Epileptogenic Brain Insult. | Q45750422 |
| | fMRI assessment of language lateralization: an objective approach. | Q45945345 |
| | In vivo mapping of temporospatial changes in glucose utilization in rat brain during epileptogenesis: an 18F-fluorodeoxyglucose-small animal positron emission tomography study. | Q45992270 |
| | From the editors: Epilepsia's survey on the necessity of the Wada test and intracranial electrodes for cortical mapping | Q46402271 |
| | Quantitative diffusion MRI of hippocampus as a surrogate marker for post-traumatic epileptogenesis | Q46869180 |
| | Simultaneous intracranial EEG and fMRI of interictal epileptic discharges in humans | Q48090815 |
| | Predictive value of 1H MRSI for outcome in temporal lobectomy | Q48111460 |
| | Imaging of P-glycoprotein-mediated pharmacoresistance in the hippocampus: proof-of-concept in a chronic rat model of temporal lobe epilepsy. | Q48127121 |
| | EEG-fMRI in the preoperative work-up for epilepsy surgery | Q48128573 |
| | EEG correlated functional MRI and postoperative outcome in focal epilepsy | Q48165842 |
| | Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714. | Q48240229 |
| | Mapping preictal and ictal haemodynamic networks using video-electroencephalography and functional imaging. | Q48248926 |
| | Intracranial EEG-fMRI analysis of focal epileptiform discharges in humans | Q48413791 |
| P433 | issue | 3 | |
| P921 | main subject | biomarker | Q864574 |
| P304 | page(s) | 315-330 | |
| P577 | publication date | 2016-11-24 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | WONOEP appraisal: Imaging biomarkers in epilepsy | |
| P478 | volume | 58 | |